ÂÜÀòÂÒÂ×

David Byram is a seasoned executive in the biopharmaceutical and healthcare consulting sectors, currently serving as a Senior Partner at EVERSANA CONSULTING where responsibility includes co-leading the Pricing, Market Access, and Reimbursement Practice in the US and EU, with expertise in oncology, rare diseases, and startup organizations. Byram previously held leadership roles at Syneos Health Consulting, Biotech Health Strategies LLC, and Braeburn, focusing on innovative commercial strategy and market access. With over 25 years of experience, Byram has a strong background in sales and marketing, HEOR, government affairs, and product launch strategies across various healthcare organizations including Gilead Sciences and Johnson & Johnson. Byram holds a Bachelor's degree in Public Administration from Indiana University Bloomington.